Low Doses of Melatonin to Improve Sleep in Children with ADHD: An Open-Label Trial.

Ana Checa-RosAntonio Muñoz-HoyosAntonio Molina-Carballo Iris Viejo-BoyanoMaricarmen ChacínValmore Bermudez Luis D' Marco

Published in: Children (Basel, Switzerland) (2023)

Low doses of melatonin (1 mg) are able to increase TST in children and adolescents with ADHD receiving treatment with psychostimulants, with an adequate tolerability profile. Further placebo-controlled trials adjusting the time of aMT administration to the individual circadian profile should explore the effects of low doses of this hormone to shorten SOL in this population of patients.

Keyphrases

attention deficit hyperactivity disorder
placebo controlled
autism spectrum disorder
newly diagnosed
end stage renal disease
study protocol
ejection fraction
double blind
phase iii
clinical trial
phase ii
open label
prognostic factors
depressive symptoms
combination therapy